ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon

Amorepacific, LG Household shine with record earnings

SEOUL -- South Korean cosmetics giants Amorepacific Group and LG Household & Health Care generated record sales and profits for the July-September quarter despite an outbreak of Middle East respiratory syndrome that deterred foreign tourists.

     Both companies saw heavy sales of high-end cosmetics at duty-free stores in South Korea and abroad. 

     Amorepacific Group generated 188.3 billion won ($168 million) in operating profit, up 8% year over year. Core unit Amorepacific's domestic business slowed as foreign tourists stayed away after the MERS outbreak. But overseas sales soared 60%. In addition to emerging markets like China and Southeast Asia, the U.S. business also grew.

     LG Household & Health Care reported a 27% jump in operating profit to 190.2 billion won. Sales rose for Whoo, su:m and other premium cosmetics brands. Toiletries such as shampoo fared well, too. Baby product brand Babience, which the company is promoting using mobile devices, logged a 53% increase in sales.

     Cosmetics are becoming a major industry in South Korea, along with electric machinery, steel and chemicals.

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

See all offers
NAR on print phone, device, and tablet media